+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania



A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania



Journal of Infectious Diseases 207(5): 848-859



Intermittent preventive treatment in infants (IPTi) is the administration of sulfadoxine-pyrimethamine (SP) at 2, 3, and 9 months of age to prevent malaria. We investigated the influence of IPTi on drug resistance. Twenty-four areas were randomly assigned to receive or not receive IPTi. Blood collected during representative household surveys at baseline and 15 and 27 months after implementation was tested for SP and resistance markers. The frequency of SP in blood was similar in the IPTi and comparison areas at baseline and at 15 months. dhfr and dhps mutations were also similar at baseline and then increased similarly in both arms after 15 months of SP-IPTi. First-line treatment was switched from SP to artemether-lumefantrine before the final survey, when SP positivity fell among infants in comparison areas but increased in IPTi areas. This was accompanied by an increase in dhfr but not dhps mutations in IPTi areas (P = .004 and P = .18, respectively). IPTi did not increase drug pressure or the selection on dhfr and dhps mutants, when SP was the first-line malaria treatment. Introduction of artemether-lumefantrine was followed by an increase in dhfr mutations, consistent with weak selection attributable to SP-IPTi, but not by an increase in dhps mutations, suggesting a fitness cost of this mutation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036730932

Download citation: RISBibTeXText

PMID: 23225897

DOI: 10.1093/infdis/jis742


Related references

Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival. Malaria Journal 10: 387, 2011

Community effectiveness of intermittent preventive treatment for infants (IPTi) in rural southern Tanzania. American Journal of Tropical Medicine and Hygiene 82(5): 772-781, 2010

Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal. Comptes Rendus Biologies 336(5-6): 295-300, 2014

Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal. American Journal of Tropical Medicine and Hygiene 88(6): 1124-1129, 2013

A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants. Clinical Infectious Diseases 45(1): 16-25, 2007

The acceptability of intermittent preventive treatment of malaria in infants delivered through the expanded programme of immunization in southern Tanzania. Malaria Journal: 213, (21 Ober), 2008

The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Malaria Journal 7: 213, 2008

A community-randomised evaluation of the effect of IPTi on anti-malarial drug resistance in southern Tanzania. 2013

Safety of sulfadoxine/pyrimethamine for intermittent preventive treatment of malaria in infants: evidence from large-scale operational research in southern Tanzania. International Health 3(3): 154-159, 2011

Intermittent Preventive Treatment (IPT): Its Role in Averting Disease-Induced Mortality in Children and in Promoting the Spread of Antimalarial Drug Resistance. Bulletin of Mathematical Biology 81(1): 193-234, 2019

Intermittent preventive antimalarial treatment in infants. Clinical Infectious Diseases 45(1): 26-28, 2007

Drug resistance maps to guide intermittent preventive treatment of malaria in African infants. Parasitology 138(12): 1469-1479, 2011

Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants. Transactions of the Royal Society of Tropical Medicine and Hygiene 103(12): 1199-1201, 2009

Follow-up survey of children who received sulfadoxine-pyrimethamine for intermittent preventive antimalarial treatment in infants. Journal of Infectious Diseases 203(4): 556-560, 2011

Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 365(9469): 1481-1483, 2005